Optimising the formulation of monoclonal antibodies
12 Jan 2018
Yes
-  

 

 

 

No

​​

 

​Monoclonal antibodies (mAbs) are an increasingly important class of medical drugs. High concentration liquid formulations are needed in order to give a clinically-effective dose in a low volume subcutaneous injection. During the optimization of these formulations it is necessary to limit the formation of aggregates and particulates. These can arise via a number of processes, including surface adsorption-desorption effects, and characterizing the precise molecular nature of adsorbed mAbs at an interface requires state-of-the-art analytical techniques and data interpretation. In a recent paper, researchers demonstrate the power of neutron reflection to unravel the amount and structural conformation of the adsorbed antibody layers at the air/water interface with and without surfactant.

Related publication: C. Smith et al. “Antibody adsorption on the surface of water studied by neutron reflection” MAbs. 9 (2017): 466-475. 

DOI: 10.1080/19420862.2016.1276141​


Contact: